Shareholding disclosure

Alllianz SE

Declared position

Threshold

Fell below threshold

Timeline

Published

01.08.2009

Transaction

30.07.2009

Transfer date

30.07.2009

Voting rights breakdown

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TA97V00033

Beneficial owner

Alllianz SE

Declared address

Alllianz SE, 80802 München

Direct shareholders held by the beneficial owner Allianz SE

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Alllianz SE

Santhera Pharmaceuticals Holding AG01.08.2009TA97V00033

Disclosure summary

Alllianz SE disclosed a holding in Santhera Pharmaceuticals Holding AG that fell below the publication threshold, published by SIX Exchange Regulation on 01.08.2009, at 3% of voting rights. Notice category: Single shareholder.

Disclosed position

Below threshold

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Alllianz SE disclosed a holding in Santhera Pharmaceuticals Holding AG, published on 01.08.2009.

Publication date01.08.2009

Transaction date30.07.2009

Transfer date30.07.2009

Issuing companySanthera Pharmaceuticals Holding AG

Beneficial ownerAlllianz SE

Declared addressAlllianz SE, 80802 München

CategorySingle shareholder

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

ExchangeXSWX

Notification IDTA97V00033

Conditions

Direct shareholders held by the beneficial owner Allianz SE

Source: SIX Exchange Regulation · Publication date: 01.08.2009

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open